Indianapolis Business Journal

MAY 31-JUNE 6, 2010

This week, read about an in-car spy device a Carmel company is marketing to parents of teen drivers and see what challenges entrepreneurial companies are facing as they try to grow. In Focus, find out what's driving a boom in refrigerated warehousing. And in A&E, Lou Harry shares his pet peeves when it comes to distractions during performances.

Front PageBack to Top

Lilly grows Alimta’s sales by shrinking market

In 2008, Eli Lilly and Co. asked drug regulators to change the label on Alimta so Lilly could no longer promote it as a treatment
for all patients suffering from non-small-cell lung cancer, but for only about 70 percent of the patients. Since then, sales
of the drug have accelerated, growing a whopping 48 percent last year.

Read More

Top StoriesBack to Top

In-car spy device could drive sales

Carmel-based CarCheckup LLC has created a cell-phone-size device that plugs into a car’s “OBD II” diagnostic port to track
a plethora of data, such as speed ranges, graphs of RPM, and numbers on how hard the car accelerated and braked. The company
is marketing the device to parents of teen drivers, among others.

Read More

FocusBack to Top

OpinionBack to Top

Race has lost its magic

I hope [Bill Benner’s May 17 column is] right and that the new management at the Speedway finds ways to bring back
the “luster” of the old 500s. But it just doesn’t appear that way.

Read More

In BriefBack to Top

Effective stats are new hurdle for U.S. drugmakers

WellPoint Inc.'s announcement of comparative effectiveness research guidelines last week marks a new era for U.S. drugmakers.
The Indianapolis-based health insurer will use studies that compare the effectiveness of one drug against another as a complement
to typical clinical trial research that compares a drug against a placebo sugar pill.

Read More